{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:27:01Z","timestamp":1782808021144,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21-DA037556"],"award-info":[{"award-number":["R21-DA037556"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["MD 20892"],"award-info":[{"award-number":["MD 20892"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["589-KG-0012"],"award-info":[{"award-number":["589-KG-0012"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.pbb.2019.02.010","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T04:11:57Z","timestamp":1551067917000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study"],"prefix":"10.1016","volume":"180","author":[{"given":"Jimmie L.","family":"Pirtle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun C.","family":"Boinpelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalakar","family":"Surineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant K.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Grasing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2019.02.010_bb0005","series-title":"FDA Briefing Document, NDA 22529, Lorcaserin","author":"Arena Pharmaceuticals","year":"2012"},{"key":"10.1016\/j.pbb.2019.02.010_bb0010","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/npp.2016.259","article-title":"Repeated 7-day treatment with the 5-HT2C agonist lorcaserin or the 5-HT2A antagonist pimavanserin alone or in combination fails to reduce cocaine vs food choice in male rhesus monkeys","volume":"42","author":"Banks","year":"2017","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0015","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/npp.2017.124","article-title":"Pharmacological modulation of 5-HT2C receptor activity produces bidirectional changes in locomotor activity, responding for a conditioned reinforcer, and mesolimbic DA release in C57BL\/6 mice","volume":"42","author":"Browne","year":"2017","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0020","series-title":"Substance Abuse and Mental Health Services Administration","article-title":"Behavioral health trends in the United States: Results from the 2014 National Survey on drug use and health. HHS publication no. SMA 15-4927 ed","author":"Center for Behavioral Health Statistics and Quality","year":"2015"},{"key":"10.1016\/j.pbb.2019.02.010_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/obr.12015","article-title":"Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs","volume":"14","author":"Chan","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.pbb.2019.02.010_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.115.228833","article-title":"Lorcaserin reduces the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys","volume":"356","author":"Collins","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.02.010_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2017.12.023","article-title":"The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders","volume":"142","author":"Collins","year":"2018","journal-title":"Neuropharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0040","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2019.02.010_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.117.246082","article-title":"Inhibition of cocaine and 3,4\u2011methylenedioxypyrovalerone (MDPV) self-administration by lorcaserin is mediated by 5-HT2C receptors in rats","volume":"364","author":"Gannon","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.02.010_bb0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.116.236307","article-title":"Effects of lorcaserin on cocaine and methamphetamine self-administration and reinstatement of responding previously maintained by cocaine in rhesus monkeys","volume":"359","author":"Gerak","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.02.010_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2009.09.010","article-title":"Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals","volume":"107","author":"Grasing","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2019.02.010_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","article-title":"Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans","volume":"4","author":"Griffiths","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2019.02.010_bb0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2015.09.028","article-title":"The 5-HT receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity","volume":"101","author":"Harvey-Lewis","year":"2015","journal-title":"Neuropharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1037\/0003-066X.58.9.697","article-title":"A perspective on judgment and choice: mapping bounded rationality","volume":"58","author":"Kahneman","year":"2003","journal-title":"Am. Psychol."},{"key":"10.1016\/j.pbb.2019.02.010_bb0080","series-title":"Thinking, Fast and Slow","author":"Kahneman","year":"2011"},{"key":"10.1016\/j.pbb.2019.02.010_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuropharm.2008.10.005","article-title":"Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens","volume":"56","author":"Leggio","year":"2009","journal-title":"Neuropharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s002130100824","article-title":"Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects","volume":"157","author":"Lukas","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.02.010_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.npp.1301414","article-title":"Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine","volume":"33","author":"Navailles","year":"2008","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.pbb.2019.02.010_bb0100","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s00213-017-4726-2","article-title":"Choice between delayed food and immediate opioids in rats: treatment effects and individual differences","volume":"234","author":"Panlilio","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.02.010_bb0105","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J","article-title":"Some comments on frequently used multiple endpoint adjustment methods in clinical trials","volume":"16","author":"Sankoh","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.pbb.2019.02.010_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/clpt.2011.20","article-title":"Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users","volume":"89","author":"Shram","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2019.02.010_bb0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/oby.2008.537","article-title":"Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women","volume":"17","author":"Smith","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pbb.2019.02.010_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","article-title":"Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718305963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718305963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:35:33Z","timestamp":1758774933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718305963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"alternative-id":["S0091305718305963"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.02.010","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}